Nightly use of 0.05 percent atropine eye drops compared with placebo results in a significantly lower incidence of myopia and a lower percentage of patients with fast myopic shift at two years among children aged 4 to 9 years without myopia at baseline, according to a study published in the Feb. 14 issue of the Journal of the American Medical Association.
0.05 percent atropine eye drops result in lower incidence of myopia
Nightly use of 0.05 percent atropine eye drops compared with placebo results in a significantly lower incidence of myopia and a lower percentage of patients with fast myopic shift at two years among children aged 4 to 9 years without myopia at baseline, according to a study published in the Feb. 14 issue of the Journal of the American Medical Association.